IRIS
LOPETUSO, Loris Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.455
AS - Asia 2.698
EU - Europa 2.327
SA - Sud America 578
Continente sconosciuto - Info sul continente non disponibili 521
AF - Africa 58
OC - Oceania 12
Totale 13.649
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.244
SG - Singapore 1.452
IT - Italia 572
IE - Irlanda 482
RU - Federazione Russa 465
BR - Brasile 424
CN - Cina 383
VN - Vietnam 332
SE - Svezia 274
DE - Germania 123
GB - Regno Unito 111
CA - Canada 107
BD - Bangladesh 105
HK - Hong Kong 105
AR - Argentina 57
IN - India 51
JP - Giappone 41
NL - Olanda 37
MX - Messico 36
AT - Austria 35
FR - Francia 34
ID - Indonesia 32
EC - Ecuador 28
CO - Colombia 27
ES - Italia 25
IQ - Iraq 24
PL - Polonia 24
FI - Finlandia 21
TR - Turchia 18
TW - Taiwan 18
BE - Belgio 17
PK - Pakistan 17
RO - Romania 17
ZA - Sudafrica 17
CR - Costa Rica 15
UA - Ucraina 15
IR - Iran 14
PH - Filippine 13
SA - Arabia Saudita 13
MY - Malesia 12
TH - Thailandia 12
AU - Australia 11
BG - Bulgaria 11
HR - Croazia 11
VE - Venezuela 11
EG - Egitto 10
JM - Giamaica 10
CL - Cile 9
KR - Corea 9
PE - Perù 9
CH - Svizzera 8
NP - Nepal 8
TT - Trinidad e Tobago 8
HN - Honduras 7
UZ - Uzbekistan 7
LU - Lussemburgo 6
TN - Tunisia 6
AZ - Azerbaigian 5
DK - Danimarca 5
EE - Estonia 5
EU - Europa 5
PA - Panama 5
UY - Uruguay 5
DZ - Algeria 4
GT - Guatemala 4
LT - Lituania 4
NI - Nicaragua 4
PY - Paraguay 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BH - Bahrain 3
ET - Etiopia 3
HU - Ungheria 3
MA - Marocco 3
PR - Porto Rico 3
QA - Qatar 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
ME - Montenegro 2
MQ - Martinica 2
NG - Nigeria 2
NO - Norvegia 2
PT - Portogallo 2
SC - Seychelles 2
SV - El Salvador 2
TZ - Tanzania 2
Totale 13.115
Salva come PNG Salva come JPEG
Città #
Singapore 955
Chandler 766
San Jose 740
Ashburn 491
Dublin 481
Dallas 298
Council Bluffs 241
Princeton 235
Jacksonville 192
Santa Clara 134
Los Angeles 133
Altamura 114
Beijing 104
Hong Kong 94
Dong Ket 93
Ho Chi Minh City 93
Wilmington 86
New York 80
Redondo Beach 66
Rome 62
Silver Spring 60
Ann Arbor 57
Atlanta 57
Buffalo 57
Hanoi 55
Moscow 50
Chieti 44
The Dalles 42
Orem 36
Nuremberg 35
São Paulo 35
Chicago 33
Frankfurt am Main 33
Phoenix 32
San Francisco 31
Tokyo 31
Montreal 30
Pescara 30
Denver 28
Falls Church 27
Columbus 26
London 24
Memphis 24
Munich 23
Kansas City 22
Taranto 20
Brussels 17
Milan 17
Norwalk 17
Brooklyn 16
Rio de Janeiro 16
Teramo 16
Houston 15
Kimball 15
Toronto 15
Stockholm 14
Hefei 13
Pune 13
Tampa 13
San José 12
Amsterdam 11
Guangzhou 11
Kingston 11
Mexico City 11
Vienna 11
Xitun 11
Baghdad 10
Boardman 10
Bologna 10
Brasília 10
Cluj-Napoca 10
Curitiba 10
Manchester 10
Naples 10
Sofia 10
Tongling 10
Warsaw 10
Bari 9
Edinburgh 9
Guayaquil 9
Helsinki 9
Palermo 9
Washington 9
Belo Horizonte 8
Calgary 8
Da Nang 8
Dhaka 8
Las Vegas 8
Louisville 8
Seattle 8
Zagreb 8
Cave Creek 7
Johannesburg 7
Lappeenranta 7
Macerata 7
Porto Alegre 7
Quito 7
Tashkent 7
Ankara 6
Biên Hòa 6
Totale 6.964
Salva come PNG Salva come JPEG
Nome #
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 969
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus 637
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 444
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): Preliminary results from a retrospective cohort study 213
Role of Helicobacter pylori infection on nutrition and metabolism 199
Assessment of crohn’s disease activity: Magnetic resonance enterography in comparison with clinical and endoscopic evaluations 162
13C-octanoic acid breath test to study gastric emptying time 151
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 149
The use of anti-spasmodics in the treatment of irritable bowel syndrome: Focus on otilonium bromide 147
Bacillus clausii and gut homeostasis: state of the art and future perspectives 143
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD? 135
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 128
Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders 124
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 119
Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor-Independent Ulcerative Colitis 117
Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center 116
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 114
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 113
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 108
Coordinated Multi-Language Translation of A Validated Symptom Questionnaire for Carbohydrate Intolerances: A Practical Structured Procedure 107
A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis 107
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 107
Proteobacteria: A common factor in human diseases 106
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 106
Beyond the HLA Genes in Gluten-Related Disorders 106
Diagnosis of Cholangiocarcinoma: The New Biological and Technological Horizons 105
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 105
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 104
Actinobacteria: A relevant minority for the maintenance of gut homeostasis 104
Food components and dietary habits: Keys for a healthy gut microbiota composition 101
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 101
Role of yeasts in healthy and impaired gut microbiota: The gut mycome 100
Assessment of neurological manifestations in hospitalized patients with COVID-19 99
The gastrointestinal microbiome - Functional interference between stomach and intestine 98
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis 98
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 97
Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system 96
Opposing functions of classic and novel IL-1 family members in gut health and disease 94
Bacteriocins and bacteriophages: Therapeutic weapons for gastrointestinal diseases? 94
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 93
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 91
Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases 91
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 90
The gut barrier: New acquisitions and therapeutic approaches 90
Ulcerative colitis 90
European Crohn's and colitis organisation topical review on treatment withdrawal ['exit strategies'] in inflammatory bowel disease 90
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis 90
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 90
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 88
Locally injected Infliximab ameliorates murine DSS colitis: Differences in serum and intestinal levels of drug between healthy and colitic mice 87
Can we predict the efficacy of anti-TNF-α agents? 87
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 86
Commensal Clostridia: Leading players in the maintenance of gut homeostasis 86
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center 86
Unfolded protein response: An essential element of intestinal homeostasis and a potential therapeutic target for inflammatory bowel disease 85
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 85
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 85
Gut microbiota modulation and mucosal immunity: Focus on Rifaximin 84
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 84
Dietary magnesium alleviates experimental murine colitis through upregulation of the transient receptor potential melastatin 6 channel 84
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 83
The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease 83
The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors 83
Commentary to “safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease” 82
Gut Virome and Inflammatory Bowel Disease 82
Microbiota and inflammatory bowel disease: An update 82
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 82
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 82
The interplay between gut microbiota and the unfolded protein response: Implications for intestinal homeostasis preservation and dysbiosis-related diseases 81
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. Pylori infection 81
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders 80
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 80
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature 79
Gut microbiota and inflammatory bowel disease: So far so gut! 79
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 79
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 78
Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota's Crosstalk 78
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 78
Intestinal permeability in physiological and pathological conditions: Major determinants and assessment modalities 77
Epidemiological evaluation of acute gastroenteritis and therapeutic approaches in Middle East Countries 77
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 77
Coeliac disease under a microscope: Histological diagnostic features and confounding factors 77
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 76
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis 76
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea 76
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 76
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study 75
Prevalence of severe irritable bowel syndrome among Italian adults. A meta-analysis 75
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: Where we stand and future perspectives 75
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 74
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 74
Bariatric procedures and microbiota: patient selection and outcome prediction 74
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 73
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 72
Considering gut microbiota disturbance in the management of Helicobacter pylori infection 72
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 72
Predicting In-Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores 72
Relationship between oral microbiota and periodontal disease: A systematic review 71
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease 71
The use of probiotics in different phases of diverticular disease 71
Totale 11.250
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022646 0 0 0 118 20 16 11 28 54 39 60 300
2022/20231.882 241 337 89 224 95 348 120 143 169 18 81 17
2023/2024849 53 36 47 51 36 186 235 87 14 37 13 54
2024/20251.774 158 348 191 54 36 112 82 96 305 84 163 145
2025/20264.521 257 152 583 463 382 167 699 287 564 413 397 157
2026/20273.136 1.107 783 604 642 0 0 0 0 0 0 0 0
Totale 13.649